For more than a decade, our Pharmaceutical Business Group’s leadership team and field account managers have worked to increase the accessibility and sales of pharmaceutical, biologic and medical diagnostic products in institutional and federal government healthcare markets. Primary responsibilities have centered on working with the Veterans Administration (VA), military (DoD) and private teaching hospitals across the United States and abroad. The WSI PBG business model delivers effective, efficient, flexible and low risk services designed to increase access and overall sales which are specifically tailored to our client’s needs and product portfolio.
Sales Teams
By strategically integrating specialty and institutional sales experience with account management expertise, our Pharmaceutical Business Group has effectively driven the sales of various pharmaceutical and diagnostic products across many specialties. The team’s proficiencies span numerous medical and surgical specialties. Within medicine, work includes Gastroenterology, Rheumatology, Cardiology, Endocrinology, Hematology/Oncology, Nephrology, Neurology, Dermatology, Psychiatry, Allergy/Immunology, Infectious Disease, Substance Abuse and all facets of primary care medicine. In the surgical specialty area, our experience includes Urology, Ophthalmology, Orthopedics, Obstetrics/Gynecology and Vascular Surgery. Additionally, our field sales specialists are highly skilled and trained at accessing and working directly with pharmacy administration, formulary management personnel as well as local, regional and national policy decision markets.
Strategic Consultants
Collectively, the consulting team at WSI has more than 100 years of combined experience working directly within these complex systems. We possess the inside knowledge, and relationships necessary to effectively develop and execute strategic marketing plans which are critical to successfully capitalize on the Federal Market potential. Areas of expertise include:
- Military Health System UFVAR preparation and submissions
- Interpretation and Direction regarding Tricare Rebate Final Ruling and Implications of the NDAA
- Federal government policy and formulary management
- Clinical and economic evaluation relevant to Federal customers
- TRICARE coverage and policy
- Government contracting and pricing
- Ability to represent clients with key VA, military and I.H.S. customers
